{Reference Type}: Case Reports
{Title}: Stargardt disease: A clinical case report of two sisters with different clinical development.
{Author}: Peñarrocha-Oltra S;Rallo-López Á;Escrivá-Pastor E;
{Journal}: Arch Soc Esp Oftalmol (Engl Ed)
{Volume}: 96
{Issue}: 12
{Year}: Dec 2021
暂无{DOI}: 10.1016/j.oftale.2020.11.012
{Abstract}: The purpose of this article is to describe the clinical manifestations and complementary diagnostic tests of two sisters aged 26 and 31 with a diagnosis of Stargardt's disease. One of them presented with an initial visual acuity of 0.7 and showed a progressive central visual loss due to the atrophy of the external layers of the retina in the subfoveal region. She was recruited to participate in a clinical trial of Avancincaptad Pegol (Zimura®), an inhibitor of C5 of the complement's system. The other sister remained asymptomatic with a visual acuity of 1 in both eyes. In both cases white-yellow pisciform lesions were observed on the posterior pole. Although there is no curative treatment for this disease, there are many lines of investigation on this topic. The clinical and diagnostic tests can confirm the disease, and provide patients with an accurate prognosis.